Loading viewer...
earnings
Format: PDF earnings
Mayne Pharma Group Limited's FY23 results presentation covering financial performance, strategic transformation including the acquisition of women's health products from TherapeuticsMD, divestment of non-core assets, and improved profitability across all business segments in the second half of FY23.
earnings
29 Pages
Genex Power
Rand Capital Q2 2024 Earnings Results
earningsearnings
17 Pages
Rand Capital Corporation
Alma Media Q1 2022 Earnings Call
earningsearnings
11 Pages
Alma Media Oyj